These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21764697)
21. [Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma]. Bi M; Yang D; Li X; Zhong K; Liu Y; Li G; Liao X; Liu X Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1020-5, 1030. PubMed ID: 22820591 [TBL] [Abstract][Full Text] [Related]
22. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance]. Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477 [TBL] [Abstract][Full Text] [Related]
23. [Melanoma antigen-3 expression in human hepatocellular carcinoma]. Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142 [TBL] [Abstract][Full Text] [Related]
24. Expression of autotaxin mRNA in human hepatocellular carcinoma. Zhang G; Zhao Z; Xu S; Ni L; Wang X Chin Med J (Engl); 1999 Apr; 112(4):330-2. PubMed ID: 11593532 [TBL] [Abstract][Full Text] [Related]
25. [Expression and its clinicopathological features of tumor rejective antigen 1 in human tissues of hepatocellular carcinoma and liver cirrhosis]. Zhang H; Huang DF; Wei Q; Hua TY; Li F; Huang JF Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):661-5. PubMed ID: 20943076 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576 [TBL] [Abstract][Full Text] [Related]
27. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma]. Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655 [TBL] [Abstract][Full Text] [Related]
28. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma]. Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465 [TBL] [Abstract][Full Text] [Related]
29. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma. Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222 [TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma]. Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315 [TBL] [Abstract][Full Text] [Related]
31. [Expression and prognostic value of Polo-like kinase 1, E-cadherin in the patients with hepatocellular carcinoma]. Chen XJ; Wu LM; Xu XB; Feng XW; Xie HY; Zhang M; Shen Y; Wang WL; Liang TB; Zheng SS Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1354-8. PubMed ID: 18241575 [TBL] [Abstract][Full Text] [Related]
32. [Expression and clinicopathological significance of GRAMD4 in hepatocellular carcinoma]. Zhang J; Tu K; Zhou Z; Zheng X; Gao J; Yao Y; Liu Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):190-3. PubMed ID: 23388340 [TBL] [Abstract][Full Text] [Related]
33. [Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence]. Zhi H; Zhan J; Deng QL; Huang ZM Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):112-5. PubMed ID: 17645845 [TBL] [Abstract][Full Text] [Related]
34. Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma. Hoffmann K; Shibo L; Xiao Z; Longerich T; Büchler MW; Schemmer P Anticancer Res; 2011 Nov; 31(11):3883-90. PubMed ID: 22110214 [TBL] [Abstract][Full Text] [Related]
35. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
36. [Expression and significance of tumor susceptibility gene 101 in hepatocellular carcinoma tissues]. Gu RJ; Wang SC; Sun G; Zhuang BW; Liu DL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):738-40. PubMed ID: 22768867 [TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
38. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma. Jeng KS; Sheen IS; Tsai YC Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142 [TBL] [Abstract][Full Text] [Related]
39. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma. Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339 [TBL] [Abstract][Full Text] [Related]
40. [Expression of two types of melanoma antigens in hepatocellular carcinoma]. Cai S; Leng X; Wang Y Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):205-7. PubMed ID: 11783086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]